954 Clinical results from a phase I dose escalation study in treatment-naïve early stage prostate cancer patients with ORCA-010, a potency enhanced oncolytic replication competent adenovirus

Bibliographic Details
Published in:Journal for ImmunoTherapy of Cancer
Main Authors: Brachtlova, Tereza, Abramovitch, Allan, Giddens, Jonathan, Incze, Peter, Jansz, Kenneth, Casey, Richard, Beusechem, Victor van, Dong, Wenliang
Format: Conference Object
Language:unknown
Published: BMJ Publishing Group Ltd 2021
Subjects:
Orca
Online Access:http://dx.doi.org/10.1136/jitc-2021-sitc2021.954
https://syndication.highwire.org/content/doi/10.1136/jitc-2021-SITC2021.954
id crjcrbmj:10.1136/jitc-2021-sitc2021.954
record_format openpolar
spelling crjcrbmj:10.1136/jitc-2021-sitc2021.954 2024-06-23T07:55:57+00:00 954 Clinical results from a phase I dose escalation study in treatment-naïve early stage prostate cancer patients with ORCA-010, a potency enhanced oncolytic replication competent adenovirus Brachtlova, Tereza Abramovitch, Allan Giddens, Jonathan Incze, Peter Jansz, Kenneth Casey, Richard Beusechem, Victor van Dong, Wenliang 2021 http://dx.doi.org/10.1136/jitc-2021-sitc2021.954 https://syndication.highwire.org/content/doi/10.1136/jitc-2021-SITC2021.954 unknown BMJ Publishing Group Ltd Late-Breaking Abstracts proceedings-article 2021 crjcrbmj https://doi.org/10.1136/jitc-2021-sitc2021.954 2024-06-06T04:16:00Z Conference Object Orca The BMJ Journal for ImmunoTherapy of Cancer 9 Suppl 2 A1004 A1004
institution Open Polar
collection The BMJ
op_collection_id crjcrbmj
language unknown
format Conference Object
author Brachtlova, Tereza
Abramovitch, Allan
Giddens, Jonathan
Incze, Peter
Jansz, Kenneth
Casey, Richard
Beusechem, Victor van
Dong, Wenliang
spellingShingle Brachtlova, Tereza
Abramovitch, Allan
Giddens, Jonathan
Incze, Peter
Jansz, Kenneth
Casey, Richard
Beusechem, Victor van
Dong, Wenliang
954 Clinical results from a phase I dose escalation study in treatment-naïve early stage prostate cancer patients with ORCA-010, a potency enhanced oncolytic replication competent adenovirus
author_facet Brachtlova, Tereza
Abramovitch, Allan
Giddens, Jonathan
Incze, Peter
Jansz, Kenneth
Casey, Richard
Beusechem, Victor van
Dong, Wenliang
author_sort Brachtlova, Tereza
title 954 Clinical results from a phase I dose escalation study in treatment-naïve early stage prostate cancer patients with ORCA-010, a potency enhanced oncolytic replication competent adenovirus
title_short 954 Clinical results from a phase I dose escalation study in treatment-naïve early stage prostate cancer patients with ORCA-010, a potency enhanced oncolytic replication competent adenovirus
title_full 954 Clinical results from a phase I dose escalation study in treatment-naïve early stage prostate cancer patients with ORCA-010, a potency enhanced oncolytic replication competent adenovirus
title_fullStr 954 Clinical results from a phase I dose escalation study in treatment-naïve early stage prostate cancer patients with ORCA-010, a potency enhanced oncolytic replication competent adenovirus
title_full_unstemmed 954 Clinical results from a phase I dose escalation study in treatment-naïve early stage prostate cancer patients with ORCA-010, a potency enhanced oncolytic replication competent adenovirus
title_sort 954 clinical results from a phase i dose escalation study in treatment-naïve early stage prostate cancer patients with orca-010, a potency enhanced oncolytic replication competent adenovirus
publisher BMJ Publishing Group Ltd
publishDate 2021
url http://dx.doi.org/10.1136/jitc-2021-sitc2021.954
https://syndication.highwire.org/content/doi/10.1136/jitc-2021-SITC2021.954
genre Orca
genre_facet Orca
op_source Late-Breaking Abstracts
op_doi https://doi.org/10.1136/jitc-2021-sitc2021.954
container_title Journal for ImmunoTherapy of Cancer
container_volume 9
container_issue Suppl 2
container_start_page A1004
op_container_end_page A1004
_version_ 1802648769232109568

Similar Items